Lifevantage Corp (LFVN) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2026, Lifevantage reported revenue of $182.6M, down 20.1% from $228.5M the year before. Net income was $5.1M (a 2.8% net margin), or $0.40 per diluted share. Gross margin was 77.6% and operating margin was 3.3%. Operating activities generated $10.2M of cash, leaving $6.7M of free cash flow. At fiscal year end, Lifevantage held $62.1M in total assets against $28.5M in total liabilities.
Open the full interactive Lifevantage financials → Quarterly statements, key ratios, valuation history and price charts.
Lifevantage Key Stats
| Share Price | $5.95 |
|---|---|
| Market Cap | $75.6M |
| P/E Ratio | 14.9 |
| Dividend Yield | 3.10% |
| Revenue YoY Growth | -20.1% |
| 52-Week Range | $3.96 – $10.62 |
| Shares Outstanding | 12.5 million (basic, 2026 Q4) |
Lifevantage Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $220.2M | $206.4M | $213.4M | $200.2M | $228.5M | $182.6M |
| Cost of Goods Sold | $38.2M | $38.1M | $43.4M | $41.4M | $44.9M | $41.0M |
| Gross Profit | $182.0M | $168.3M | $170.0M | $158.7M | $183.7M | $141.6M |
| Operating Income | $17.6M | $7.6M | $4.3M | $4.3M | $12.2M | $6.1M |
| Pre-Tax Income | $17.2M | $4.7M | $4.0M | $4.3M | $12.2M | $6.1M |
| Income Tax | $4.3M | $1.6M | $1.5M | $1.4M | $2.4M | $994,000 |
| Net Income | $12.9M | $3.1M | $2.5M | $2.9M | $9.8M | $5.1M |
| Diluted EPS | $0.90 | $0.24 | $0.20 | $0.23 | $0.75 | $0.40 |
Lifevantage Quarterly Results
| 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | |
|---|---|---|---|---|
| Revenue | $47.6M | $48.9M | $43.7M | $42.4M |
| Net Income | $2.2M | $276,000 | $1.4M | $1.3M |
| Diluted EPS | $0.17 | $0.02 | $0.11 | $0.10 |
Lifevantage Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $23.2M | $20.2M | $21.6M | $16.9M | $20.2M | — |
| Current Assets | $48.1M | $47.0M | $44.3M | $37.6M | $50.9M | $38.3M |
| Total Assets | $78.7M | $70.7M | $66.1M | $60.3M | $72.0M | $62.1M |
| Current Liabilities | $25.2M | $25.7M | $19.6M | $22.3M | $27.2M | $20.2M |
| Total Liabilities | $41.9M | $39.2M | $31.5M | $34.3M | $37.3M | $28.5M |
| Shareholders' Equity | $36.8M | $31.5M | $34.6M | $26.0M | $34.6M | $33.6M |
Lifevantage Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $16.3M | $8.0M | $6.8M | $12.2M | $11.9M | $10.2M |
| Cash From Investing | -$3.7M | -$1.5M | -$3.1M | -$2.2M | -$1.4M | -$7.3M |
| Cash From Financing | -$11.5M | -$9.0M | -$2.4M | -$14.4M | -$7.6M | -$7.8M |
| Free Cash Flow | $12.5M | $6.4M | $3.8M | $10.0M | $10.5M | $6.7M |
| Dividends Paid | — | $378,000 | $1.6M | $6.9M | $2.1M | $2.3M |
Figures from Lifevantage's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Lifevantage financials page for every line item.
Lifevantage Company Profile
| Ticker | LFVN |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Lehi, Utah |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer, smaller reporting company |
| SEC CIK | 0000849146 |
Frequently Asked Questions
What was Lifevantage's revenue in fiscal 2026?
Lifevantage (LFVN) reported revenue of $182.6M for fiscal 2026.
What is Lifevantage's annual revenue history?
Lifevantage's annual revenue by fiscal year: 2021: $220.2M; 2022: $206.4M; 2023: $213.4M; 2024: $200.2M; 2025: $228.5M; 2026: $182.6M.
What was Lifevantage's net income in fiscal 2026?
Lifevantage reported net income of $5.1M for fiscal 2026.
What was Lifevantage's earnings per share (EPS) in fiscal 2026?
Lifevantage's diluted EPS was $0.40 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Lifevantage generate in fiscal 2026?
Lifevantage generated $6.7M of free cash flow in fiscal 2026.
What was Lifevantage's revenue last quarter?
In its most recent reported quarter (2026 Q4), Lifevantage reported revenue of $42.4M.
How many shares of Lifevantage are outstanding?
Lifevantage reported a weighted average of 12.5 million basic shares outstanding in 2026 Q4.
What is Lifevantage's market cap?
Based on its latest closing price, Lifevantage (LFVN) has a market capitalization of about $75.6M.
When does Lifevantage's fiscal year end?
Lifevantage's fiscal year end, as registered with the SEC, is December 31.
Where is Lifevantage headquartered?
Lifevantage lists its business address in Lehi, Utah in its SEC filings.